Adipose-derived stem cell stimulation using poly-L-lactic acid injection

Table 2 Antibody information, concentration gradients, optimal concentration, and respective positive control tissues for antibody validation

Antibody	SKU#	Concentration gradient	Optimal concentration	Control tissue
PCNA	60097-1-IG	1:500, 1:1000, 1:2000	1:500	Human tonsil
CD90	66766-1-IG	1:250, 1:500, 1:1000	1:250	Human hippocampus
CD105	10862-1-AP	1:1000, 1:2000, 1:4000	1:1,000	Human testis
CD31	MA3105	3 μg/mL, 9 μg/mL, 15 μg/mL	15 μg/mL	Human lung
Adiponectin	TA804768	1:50, 1:100, 1:200	1:50	Human adipose tissue
Pref-1	29288-1-AP	1:100, 1:200, 1:500	1:100	Human placenta
β-catenin	13-8400	1:100, 1:500, 1:1000	1:100	Human tonsil
PLIN1	66936-1-IG	1:50, 1:100, 1:200	1:100	Human adipose tissue
PPARγ	9349	1:250, 1:500, 1:1000	1:250	Human tonsil
CD68	ab289671	1:500, 1:1000, 1:2000	1:500	Human lung
CD80	ab315832	1:50, 1:100, 1:200	1:100	Human lymph
CD163	MA5-32684	1:50, 1:100, 1:200	1:50	Human lung

PCNA: Proliferating cell nuclear antigen; Pref-1: Preadipocyte factor 1; PLIN1: Perilipin 1; PPAR-γ: Peroxisome proliferator-activated receptor gamma.